Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial

---

Bastidas A., de la Serna J., El Idrissi M., Oostvogels L., Quittet P., Lopez-Jimenez J., ...Daha Fazla

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, cilt.322, sa.2, ss.123-133, 2019 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 322 Sayı: 2
• Basım Tarihi: 2019
• Doi Numarası: 10.1001/jama.2019.9053
• Dergi Adı: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.123-133
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• Ankara Üniversitesi Adresli: Evet

Özet

IMPORTANCE Herpes zoster, a frequent complication following autologous hematopoietic stem cell transplantation (HSCT), is associated with significant morbidity. A nonlive adjuvanted recombinant zoster vaccine has been developed to prevent posttransplantation zoster.